Apixaban-[13C,d7]
Isotopic labelled form of Apixaban. Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
| Supplier | BOC Sciences |
|---|---|
| Product # | BLP-003322 |
| Pricing | Inquire |
| Molecular Weight | 467.53 |
| Molecular Formula | C24[13C]H18D7N5O4 |
| Canonical SMILES | COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N |